TRV GP Iv, LLC, 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 954,802 shares at $10.15 ($9.7M) on 2025-10-23, disclosed to the SEC on 2025-10-27.
Open-market sale of $9.7M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.15 | 477,401 | $4.8M | 50.0% |
| 2 | $10.15 | 477,401 | $4.8M | 50.0% |
| Total | $10.15 avg | 954,802 | $9.7M | 100% |
| Filing → |
| TNGX | SELL | 2025-09-09 | $5.7M | — | Filing → |
| TNGX | SELL | 2024-09-17 | $710K | — | Filing → |
| TNGX | SELL | 2024-09-09 | $867K | — | Filing → |